Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
The SpaceX mission
A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station. Slideshow
U.S. OKs Merck shot to prevent male genital warts
LOS ANGELES |
LOS ANGELES (Reuters) - Merck & Co won U.S. approval to sell its cervical cancer vaccine for prevention of genital warts in boys and young men, the company said on Friday.
The Food and Drug Administration approved the Gardasil vaccine for males ages 9 through 26, Merck said in a statement. Gardasil fights infection with the human papillomavirus (HPV), which causes cervical cancer and genital warts.
Gardasil already is sold for girls and women to prevent cervical cancer.
Merck shares fell 5 cents to $33.25 on the New York Stock Exchange at mid-afternoon.
(Reporting by Lisa Richwine; Editing by Richard Chang)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters